Development of novel monoclonal antibodies against CD109 overexpressed in human pancreatic cancer

Gustavo A. Arias-Pinilla; Angus G. Dalgleish; Satvinder Mudan; Izhar Bagwan; Anthony J. Walker; Helmout Modjtahedi

doi:10.18632/oncotarget.25017

Development of novel monoclonal antibodies against CD109 overexpressed in human pancreatic cancer

Gustavo A. Arias-Pinilla
, Angus G. Dalgleish
, Satvinder Mudan
, Izhar Bagwan
, Anthony J. Walker
, Helmout Modjtahedi

Research output: Contribution to journal › Article › peer-review

4 Downloads (Pure)

Original language	English
Pages (from-to)	19994-20007
Journal	Oncotarget
Volume	9
DOIs	https://doi.org/10.18632/oncotarget.25017
Publication status	Published - 13 Apr 2018

Keywords

Biological sciences

Access to Document

10.18632/oncotarget.25017

Ariaspinilla-G-40832-VoRFinal published version, 3.35 MBLicence: CC BY

https://doi.org/10.18632/oncotarget.25017

Cite this

@article{9d43f5cc386c47fe8ae3918e1b92556a,

title = "Development of novel monoclonal antibodies against CD109 overexpressed in human pancreatic cancer",

keywords = "Biological sciences",

author = "Arias-Pinilla, \{Gustavo A.\} and Dalgleish, \{Angus G.\} and Satvinder Mudan and Izhar Bagwan and Walker, \{Anthony J.\} and Helmout Modjtahedi",

year = "2018",

month = apr,

day = "13",

doi = "10.18632/oncotarget.25017",

language = "English",

volume = "9",

pages = "19994--20007",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals LLC",

}

TY - JOUR

T1 - Development of novel monoclonal antibodies against CD109 overexpressed in human pancreatic cancer

AU - Arias-Pinilla, Gustavo A.

AU - Dalgleish, Angus G.

AU - Mudan, Satvinder

AU - Bagwan, Izhar

AU - Walker, Anthony J.

AU - Modjtahedi, Helmout

PY - 2018/4/13

Y1 - 2018/4/13

KW - Biological sciences

UR - http://www.oncotarget.com/index.php?journal=oncotarget

U2 - 10.18632/oncotarget.25017

DO - 10.18632/oncotarget.25017

M3 - Article

SN - 1949-2553

VL - 9

SP - 19994

EP - 20007

JO - Oncotarget

JF - Oncotarget

ER -

Development of novel monoclonal antibodies against CD109 overexpressed in human pancreatic cancer

Keywords

Access to Document

Other files and links

Cite this